Bicara Therapeutics Files for 11.765M Share IPO at $16-$18/sh
Bicara Therapeutics (BCAX) has filed for 11,765,000 share IPO at $16-$18 per share. This post appeared first on investing.com
Bicara Therapeutics (BCAX) has filed for 11,765,000 share IPO at $16-$18 per share. This post appeared first on investing.com
Investing.com — Airbus SE (EPA:AIR) on Friday reported a slight dip in deliveries in August, with the company delivering 47 aircraft and
Investing.com – India stocks were lower after the close on Friday, as losses in the Public Sector Undertakings, Oil & Gas and
By Maria Martinez and John O’Donnell BERLIN (Reuters) – Having lost cheap energy from Russia and facing uncertainty over its once-lucrative trade ties
By Paul Sandle LONDON (Reuters) -Britain’s antitrust regulator said on Friday it had provisionally found Alphabet (NASDAQ:GOOGL)’s Google had abused its dominant position
Investing.com — Shares of Sectra AB (ST:SECTb) jumped on Friday following its first-quarter earnings report. The company reported a 44%
(Reuters) -Star Entertainment will sell its interest in the Treasury Brisbane Casino building in Queensland for A$67.5 million ($45.47 million), the embattled
Zenas BioPharma (ZBIO) has filed for 11,760,000 share IPO at $16-$18 per share. This post appeared first on investing.com
Investing.com — Shares of Elis (EPA:ELIS) slumped by 16% on Friday following a Reuters report that the French workplace supplies company had
Qualcomm (NASDAQ:QCOM) has considered acquiring parts of Intel’s (NASDAQ:INTC) design business to strengthen its product offerings, Reuters reported on Thursday. The mobile chipmaker